Lana Pine is a journalist who specializes in healthcare reporting. She writes for HCP Live and Cliggott Publishing Co, and her work has also been featured in Contagion_Live, AJMC - The American Journal of Managed Care, Contemporary Pediatrics, and Contemporary OB/GYN. Lana focuses on topics such as rheumatoid arthritis, fibromyalgia, gout, and other areas of healthcare research and treatment.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Lana Pine's coverage primarily focuses on healthcare and pharmaceutical topics, particularly pertaining to conditions such as gout, rheumatoid arthritis, fibromyalgia, and biosimilars. Her articles frequently cite data and include expert commentary.
Given Lana's focus on these specific medical conditions and treatments, she would likely be interested in hearing from experts who can provide insights into the latest research findings or clinical developments related to these areas. This could include researchers with access to new data or those at the forefront of innovative treatments.
While Lana does not specify a geographic focus, her coverage appears to take an international perspective on healthcare issues without being limited by location. Therefore, relevant experts from any region may find their insights valuable for her audience.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Prolonged gout, repeated flares, and severe pain impact the psychological status of patients.
The study highlighted the potential role of shared decision-making in building trust in physicians among patients with SLE.
By: Lana Pine
The most commonly reported symptoms were bodily pain, joint tenderness and swelling, and joint pain.
By: Lana Pine
All eligible patients self-administered guselkumab using the One-Press autoinjector pen. Subjects reported pain at the injection site was significantly reduced with the One-Press autoinjector pen and 98% chose the pen as their preferred medication delivery system. Additionally, all patients stated the One-Press autoinjector pen easier to use than the syringe method. Subjects perceived more safety during the self-injection process using the autoinjector pen compared with self-injection using the prefilled syringe.
A total of 10,535 subjects (600 patients and 9935 controls) were enrolled in the cross-sectional study. Obesity was more prevalent among patients with gout and obesity indicators were significantly higher in this group. After adjusting for confounders, obesity, as defined by WC, WHR, BMI, and VFA, was shown to be linked to greater gout prevalence, with odds ratios (ORs) of 1.691, 1.858, 1.775, and 1.578, respectively (
A machine learning (ML) study provided new insights into potential pathways for detection, prevention, and management strategies for arthritis linked to environmental exposures.
By: Lana Pine
A 2-part model demonstrated significantly higher total annual health care costs in the RA group compared with the non-RA group.
By: Lana Pine
Results showed comparable clinically meaningful improvements in health-related quality of life among patients treated with the adalimumab reference product and biosimilar adalimumab-adbm.
Published on: The rheumatology month in review highlights a growing body of evidence supporting bimekizumab's use in treating psoriatic
By: Lana Pine
Listen Key Takeaways Telemedicine adoption surged during COVID-19, becoming a permanent fixture in healthcare, offering convenience and reducing exposure risks.
(833) 317-6278 
